RYTM Stock Analysis: Buy, Sell, or Hold?
RYTM - Rhythm Pharmaceuticals, Inc. Common Stock
$86.97
9.72 (12.58%)
▲
5d:
+5.3%
30d:
-8.39%
90d:
-22.73%
HOLD
MODERATE Confidence
Analysis Updated: Mar 31, 2026 12:00 AM ET
Earnings: May 06, 2026
Smart Money Accumulation
RYTM is down 8.7% this week, but smart money is accumulating calls. Top strike: $85 2026-05-15 with 1 OI. Call ratio: 100% View Scanner →
Strength: 9.4/10
Get Alerted When RYTM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RYTM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: RYTM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: RYTM is currently trading at $86.97, which is considered fair relative to its 30-day fair value range of $83.82 to $95.85.
Technical Outlook: Technically, RYTM is in a downtrend. Immediate support is located at $74.50, while resistance sits at $100.00. The stock is showing strong short-term momentum, up 12.6% recently.
Market Sentiment: RYTM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $137.27 (+57.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RYTM is in a downtrend. Immediate support is located at $74.50, while resistance sits at $100.00. The stock is showing strong short-term momentum, up 12.6% recently.
Market Sentiment: RYTM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $137.27 (+57.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$83.82 -
$95.85
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
55.3%
Protect Your Profits
Holding RYTM? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+12.6%)
- BULLISH: Trading 57.8% below Wall St target ($137.27)
Fair Price Analysis
30-Day Fair Range
$83.82 -
$95.85
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$74.50
Resistance Level
$100.00
Current Trend
Downtrend
Technical data as of
Mar 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-265.48
Wall Street Target
$137.27
(+57.8%)
Revenue Growth (YoY)
36.9%
Profit Margin
-103.6%
Share & Embed Analysis
Last updated: March 31, 2026 10:36 PM ET
Data refreshes hourly during market hours. Next update: 11:36 PM
Data refreshes hourly during market hours. Next update: 11:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RYTM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
Christopher Paul German
SELL
5614 shares
2026-03-04
Hunter C Smith
SELL
4385 shares
2026-02-19
Hunter C Smith
SELL
3569 shares
2026-02-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$54 | 65 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$222 | 57 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 59 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 54 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 43 HOLD |
Advanced RYTM Option Strategies
Professional options setups generated by AI based on today's RYTM price and gamma walls.
